Image‐guided fine‐needle aspiration cytology and flow cytometry phenotyping of neck lymphadenopathy for the diagnosis of recurrent lymphoma. (18th January 2017)

• Record Type: Journal Article
• Authors: Lumachi, F.; Fassina, A.; Tozzoli, R.; Tregnaghi, A.; Basso, S.M.M.; Ermani, M.
• Is Part Of: Clinical otolaryngology. Volume 42:Number 3(2017:Jun.)
• Page Start: 668
• Page End: 672
• Publication Date: 2017-01-18
• Subjects: Otolaryngology -- Periodicals; 617.51005
• DOI: 10.1111/coa.12797
• Languages: English
• ISSNs: 1749-4478

Abstract

Abstract : Objective: In patients with a history of lymphoma, each lymphadenopathy should be carefully evaluated. The aims of this study were to evaluate (i) the usefulness of high‐resolution ultrasonography (US), US‐guided fine‐needle aspiration cytology (FNAC) and flow cytometry phenotyping (FCP) together in the diagnosis of recurrent lymphoma and (ii) whether these tools were independent predictors of correct results. Design: Retrospective cohort study with stepwise forward logistic regression analysis of results. Setting: Tertiary referral centre. Participants: A total of 151 patients with a history of lymphoma who developed a cervical mass during follow‐up. Methods: On neck US, a lymphadenopathy was shown in 129 (85.4%) patients (median age 57 years, range 18–78 years), and US‐guided FNAC combined with FCP were immediately performed. All patients had surgical excision and subsequent histological examination of the enlarged node(s), to establish lymphoma subclassification. Results: Final histology confirmed recurrence in 82 (63.6%) patients. According to the logistic regression analysis, FNAC and FCP were independent predictors of correct results ( P = 0.009 and 0.028, respectively) and did not interfere with each other. The sensitivity, specificity and accuracy of the combination of all of the tools were 98.8%, 100% and 99.2%, respectively, and the area under the receiver operating characteristic curve was 0.902 (95% CI: 0.797–0.986). Conclusion: This minimally invasive procedure is easily performed and should be recommended for all patients with cervical lymphadenopathy and a history of lymphoma, avoiding the need of core‐biopsy or surgical excision if recurrence was excluded.